March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain ... not mention the issue in Friday's news release. The company has an existing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback